✦ LIBER ✦

Long-Term Course of West Syndrome Associated with Tuberous Sclerosis

✍ Scribed by Katsuyuki Fukushima; Yushi Inoue; Tateki Fujiwara; Kazuichi Yagi

Book ID: 109106747
Publisher: Wiley (Blackwell Publishing)
Year: 1998
Tongue: English
Weight: 614 KB
Volume: 39
Category: Article
ISSN: 0013-9580
DOI: 10.1111/j.1528-1157.1998.tb05151.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Follow-Up of Childhood Epileps

Long-Term Follow-Up of Childhood Epilepsy Associated with Tuberous Sclerosis

✍ Yoko Ohtsuka; Iori Ohmori; Eiji Oka 📂 Article 📅 1998 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 507 KB

Long-term treatment of antiphospholipid

Long-term treatment of antiphospholipid syndrome-associated cerebral arterial thromboses with intravenous immunoglobulin: a case report

✍ B. Arabshahi; E. D. Thompson; E. M. Smergel; D. P. Goldsmith 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 90 KB

Long-term effect of betaine on risk fact

Long-term effect of betaine on risk factors associated with the metabolic syndrome in healthy subjects

✍ Schwab, U; Alfthan, G; Aro, A; Uusitupa, M 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 260 KB

Fibrous dysplasia associated with intram

Fibrous dysplasia associated with intramuscular myxoma (Mazabraud's syndrome): a long-term follow-up of three cases

✍ Miklós Szendrói; Pál Rahóty; Imre Antal; János Kiss 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 384 KB

Long-term remission of pulmonary veno-oc

Long-term remission of pulmonary veno-occlusive disease associated with primary Sjögren’s syndrome following immunosuppressive therapy

✍ Taio Naniwa; Yutaka Takeda 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 242 KB

Long-term foscarnet therapy not associat

Long-term foscarnet therapy not associated with the development of foscarnet-resistant human immunodeficiency virus type 1 in an acquired immunodeficiency syndrome patient

✍ Gilda Tachedjian; Jenny Hoy; Kate McGavin; Chris Birch 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB

Sequential human-immunodeficiency virus type 1 (HIV-1) isolates from an acquired immunodeficiency syndrome (AIDS) patient on long-term foscarnet and zidovudine therapy were examined for the emergence of foscarnet resistance. One isolate obtained before therapy, and three postfoscarnet therapy HIV is